MESCHIARI, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 11.222
EU - Europa 7.093
AS - Asia 7.078
SA - Sud America 1.071
AF - Africa 189
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.686
Nazione #
US - Stati Uniti d'America 10.832
IT - Italia 3.025
SG - Singapore 2.157
CN - Cina 1.617
GB - Regno Unito 1.174
VN - Vietnam 842
HK - Hong Kong 759
BR - Brasile 744
DE - Germania 522
SE - Svezia 504
BD - Bangladesh 479
RU - Federazione Russa 356
FI - Finlandia 342
FR - Francia 301
CA - Canada 240
KR - Corea 232
NL - Olanda 224
ID - Indonesia 185
IN - India 180
AR - Argentina 111
TR - Turchia 97
BG - Bulgaria 83
MX - Messico 76
ES - Italia 74
LT - Lituania 66
UA - Ucraina 66
JP - Giappone 64
ZA - Sudafrica 63
PL - Polonia 58
IQ - Iraq 56
CO - Colombia 54
IR - Iran 52
CL - Cile 46
EC - Ecuador 44
AE - Emirati Arabi Uniti 43
PK - Pakistan 42
IE - Irlanda 39
MY - Malesia 36
AT - Austria 34
CZ - Repubblica Ceca 33
SI - Slovenia 32
MA - Marocco 30
BE - Belgio 27
TH - Thailandia 27
AU - Australia 25
CH - Svizzera 22
SA - Arabia Saudita 22
JO - Giordania 21
PH - Filippine 21
VE - Venezuela 21
UZ - Uzbekistan 18
RO - Romania 17
EG - Egitto 15
IL - Israele 15
NP - Nepal 15
PE - Perù 15
PY - Paraguay 15
CR - Costa Rica 14
KZ - Kazakistan 14
TN - Tunisia 14
GR - Grecia 13
DO - Repubblica Dominicana 12
BO - Bolivia 11
KE - Kenya 11
TW - Taiwan 11
DZ - Algeria 10
JM - Giamaica 10
AZ - Azerbaigian 9
PS - Palestinian Territory 9
AL - Albania 8
HU - Ungheria 8
LV - Lettonia 8
NO - Norvegia 8
UY - Uruguay 8
GE - Georgia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
BH - Bahrain 6
DK - Danimarca 6
NG - Nigeria 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
ET - Etiopia 5
PR - Porto Rico 5
BB - Barbados 4
CI - Costa d'Avorio 4
CY - Cipro 4
MD - Moldavia 4
NI - Nicaragua 4
RS - Serbia 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BF - Burkina Faso 3
BZ - Belize 3
CG - Congo 3
EE - Estonia 3
Totale 26.613
Città #
Ashburn 1.528
Singapore 1.363
Santa Clara 1.313
Fairfield 763
Hong Kong 733
San Jose 675
Southend 649
Chandler 637
Hefei 530
Council Bluffs 331
Nyköping 330
Woodbridge 299
Houston 289
Cambridge 287
Los Angeles 285
New York 280
London 279
Ho Chi Minh City 276
Seattle 268
Helsinki 264
Beijing 258
Seoul 223
Wilmington 211
Milan 210
Rome 194
Bologna 188
Dallas 185
Hanoi 185
Modena 184
Munich 162
Chicago 158
Jakarta 147
San Diego 137
The Dalles 116
Ann Arbor 114
Lauterbourg 98
Shanghai 94
Moscow 90
Buffalo 87
Princeton 75
Toronto 74
São Paulo 70
Sofia 69
Frankfurt am Main 66
Naples 62
Parma 59
Boardman 55
Bremen 54
Amsterdam 53
Orem 52
Tokyo 50
Jacksonville 47
Warsaw 47
Atlanta 44
Da Nang 44
Turku 44
Dearborn 43
Hillsboro 41
Montreal 40
North York 38
Palermo 38
Paris 38
Turin 38
Phoenix 36
Reggio Emilia 36
Salt Lake City 36
Redwood City 35
Florence 33
Fremont 33
Johannesburg 31
Nuremberg 30
Stockholm 30
Brooklyn 29
Catania 28
Denver 28
Dublin 28
Kent 28
Redondo Beach 28
Bari 27
Rio de Janeiro 27
Chennai 26
Haiphong 26
Mexico City 26
Mumbai 26
Poplar 25
Columbus 24
Santiago 24
Verona 24
Madrid 23
Brussels 22
Lappeenranta 22
Portsmouth 22
Rimini 22
Belo Horizonte 21
Des Moines 21
Grafing 21
Izmir 21
Biên Hòa 20
Dong Ket 20
Guangzhou 20
Totale 16.640
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 806
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 694
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 557
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 518
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 474
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 462
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 454
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 439
Metabolic reprograming shapes neutrophil functions in severe COVID-19 414
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 407
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 402
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 378
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 376
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 372
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 370
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 369
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 369
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 366
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 350
Ectopic fat is linked to prior cardiovascular events in men with HIV. 345
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 338
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 335
Hypokalemia in Patients with COVID-19 329
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 328
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 320
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 293
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 292
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 289
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 285
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 275
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 269
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 268
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 267
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 264
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 261
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 256
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 255
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 254
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 251
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 250
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 247
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 244
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 243
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 242
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 240
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 239
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 236
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 233
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 231
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 230
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 230
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 225
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 224
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 214
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 214
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 214
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 212
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 212
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 211
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 211
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 210
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 205
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 204
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 201
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 201
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 201
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 200
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 199
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 198
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 195
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 187
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 187
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 183
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 179
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 173
Fusobacterium necrophorum septic arthritis of the hip: a case-report and literature review 171
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 168
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 167
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 166
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 166
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 165
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 164
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 164
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 160
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 160
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 160
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study project 159
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 156
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 150
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 142
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 142
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 137
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 137
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 134
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 131
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 127
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Horse Rider Patient: A Case Report and Literature Review 126
Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy 119
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 118
Knowledge, practices, educational needs and hospital engagement in Infection Prevention and Control (IPC) among Italian healthcare workers and students: results from a national multicentre survey 116
Totale 25.781
Categoria #
all - tutte 110.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.196 149 130 167 68 114 147 261 122 228 160 402 248
2022/20232.383 270 292 190 215 234 271 74 203 271 71 139 153
2023/20242.249 89 132 160 192 370 219 169 253 100 105 179 281
2024/20255.474 196 120 133 387 897 865 439 327 604 311 543 652
2025/202611.146 813 493 882 1.208 1.391 584 1.326 585 1.110 1.140 910 704
2026/2027358 358 0 0 0 0 0 0 0 0 0 0 0
Totale 26.943